Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
PennantPark Investment Corporation Announces Public Offering of Unsecured Notes Due 2024
-
AppTech Corp. Announces Launch of Up to $10 Million Offering
-
AppTech Corp. Announces Launch of Up to $10 Million Offering
-
Aeterna Zentaris (AEZS) Prices Approximately $5 Million Registered Direct Offering of Common Stock, Warrants
-
Aeterna Zentaris Announces Pricing of Approximately $5.0 Million Registered Direct Offering
-
Aeterna Zentaris Announces Pricing of Approximately $5.0 Million Registered Direct Offering
-
TOP Ships (TOPS) PT Lowered to $6 at Maxim Group
-
Celsius Holdings Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Fastbase Inc. Shareholder and Investor Update for Q3 2019
-
Aegis Capital Corp. is pleased to announce its commitment to Equity Research
-
Top Ships (TOPS) Prices 1.58M Stock Offering w/Warrants
-
TOP Ships Inc. Announces Pricing of Approximately $10 Million Underwritten Public Offering
-
Apple (AAPL) PT Lowered to $204 at Maxim Group
-
Co-Diagnostics Expects New Royalty Structure to Lift Revenue and Expand Customer Base
-
Co-Diagnostics Expects New Royalty Structure to Lift Revenue and Expand Customer Base
-
Maxim Group Downgrades Recon Technology (RCON) to Hold
-
Maxim Group Starts American Resources Corp. (AREC) at Buy
-
BioPharmX Corp (BPMX) PT Lowered to $1 at Maxim Group
-
UPDATE: Maxim Group Downgrades Neurotrope (NTRP) to Hold
-
Maxim Group Starts Kura Sushi USA Inc. (KRUS) at Buy
-
Maxim Group Starts Del Mar Pharma (DMPI) at Buy
-
Capstone Turbine (CPST) PT Lowered to $0.70 at Maxim Group
-
Achieve Life Sciences to Host Investor Day on September 20th Including Roundtable Discussion with Smoking Cessation Medical Experts and Final Data from the Phase 2b ORCA-1 Trial
-
Domino's Pizza (DPZ) PT Lowered to $280 at Maxim Group
-
Bio-Key International (BKYI) PT Lowered to $2 at Maxim Group
-
Pitney Bowes (PBI) PT Lowered to $6 at Maxim Group
-
American Resources Corp. (AREC) Prices 3.6M Share Common & Warrants Offering at $1.05/Unit
-
American Resources Corporation Announces Pricing of $3.8 Million Offering of Common Stock and Warrants
-
Maxim Group Downgrades Nxt-ID, Inc. (NXTD) to Hold
-
Theralase Announces Closing of Prospectus Offering for Gross Proceeds of $17,250,000
-
Maxim Group Upgrades Pure Storage (PSTG) to Buy
-
Maxim Group Downgrades Hemispherx (HEB) to Hold
-
American Resources Corp. (AREC) Announces Proposed Common Share & Warrants Offering
-
American Resources Corporation Announces Proposed Public Offering of Common Stock and Warrants
-
ToughBuilt Announces Financing with Institutional Investor
-
Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering
-
Guardion Health Sciences Closes $5.8 Million Underwritten Public Offering
-
Maxim Group Downgrades Titan Pharmaceuticals (TTNP) to Hold
-
Guardion Health Sciences (GHSI) Raises Pricing on 13M Share Offering to $0.45/Sh (from $0.40/Sh)
-
Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering
-
Guardion Health Sciences Announces an Increase in the Pricing of its Previously Announced Underwritten Public Offering
-
Maxim Group Downgrades Abeona Therapeutics (ABEO) to Hold
-
Cardax, Inc. (CDXI) Announces Proposed Follow-On Share Offering Up to $15M
-
Cardax Files Registration Statement for Proposed $15 Million Follow-On Offering
-
Delmar Pharma (DMPI) Prices 6.75M Share Common Offering at $1/Sh
-
DelMar Pharmaceuticals Announces Pricing Of $6.8 Million Underwritten Public Offering
-
Guardion Health Sciences (GHSI) Announces Pricing of $5.2 Million Underwritten Public Offering of Common Stock, Warrants
-
Inpixon (INPX) Prices $4.8 Million Public Offering of Common Stock, Warrants
-
Inpixon Prices $4.8 Million Public Offering
-
Guardion Health Sciences Announces Pricing of $5.2 Million Underwritten Public Offering

